Furthermore, the ICC adds SETBP1 and ASXL1 mutations as molecular supportive criteria and the WHO-HAEM5 adds SETBP1 and ETNK1 mutations. The gene discussed is SETBP1; the disease is intrahepatic cholangiocarcinoma.